Garuda - Garba Rujukan Digital

p-Index From 2020 - 2025

4.071

P-Index

This Author published in this journals

All Journal Saintika Medika: Jurnal Ilmu Kesehatan dan Kedokteran Keluarga. Jurnal Berkala Epidemiologi Folia Medica Indonesiana Indonesian Journal of Cancer The Indonesian Biomedical Journal Health Notions Syntax Literate: Jurnal Ilmiah Indonesia MAGNA MEDICA: Berkala Ilmiah Kedokteran dan Kesehatan Majalah Patologi Indonesia Biomolecular and Health Science Journal JUXTA: Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga Majalah Biomorfologi (Biomorphology Journal) Jurnal Layanan Masyarakat (Journal of Public Service) Jurnal Pengabdian Masyarakat dalam Kesehatan Narra J Indonesian Journal of Cancer Jurnal Pengabdian Masyarakat Bhinneka Jurnal Pengabdian Masyarakat Bangsa

DYAH FAUZIAH, DYAH

Departemen Patologi Anatomi RS Dr. Soetomo Fakultas Kedokteran Universitas Airlangga Surabaya

Author-ID : 2392253

Agriculture, Biological Sciences & Forestry Arts Humanities Biochemistry, Genetics & Molecular Biology Civil Engineering, Building, Construction & Architecture Computer Science & IT Decision Sciences, Operations Research & Management Dentistry Economics, Econometrics & Finance Education Energy Environmental Science Health Professions Immunology & microbiology Industrial & Manufacturing Engineering Law, Crime, Criminology & Criminal Justice Mathematics Medicine & Pharmacology Neuroscience Nursing Physics Public Health Social Sciences Other

Published : 51 Documents Claim Missing Document

Claim Missing Document

Articles

2 3 4 5 6

Evaluating Outcome in Perforated Peptic Ulcer by Boey and POMPP Score Elvin Nuzulistina; Mamiek Dwi Putro; Dyah Fauziah
JUXTA: Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga Vol. 12 No. 1 (2021): Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga
Publisher : Faculty of Medicine Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/juxta.V12I12021.14-18

Introduction: Perforated peptic ulcer (PPU) is able to increase the risk of mortality and morbidity. This study used Boey and practical scoring system of mortality in patients with perforated peptic ulcer (POMPP) scoring systems to assess risk mortality of the patients. Every parameter has a value to add up 1 point in Boey and POMPP score. Methods: This observational study used medical records of PPU patients who came to Dr. Soetomo General Hospital in emergency state and being operated and treated at surgical inpatient care facility in 2016. The data were analyzed retrospectively. The sampling technique in this study was done by total sampling. Results: Most of PPU patients had the average age of 59.56 years old and 71.79% of the patients were male. Both analyzing results of Boey and POMPP scoring systems were not statistically significant to predict mortality risk of the patients. Even so, the results of Boey scoring system tended to have a positive correlation with mortality risk (0%, 37.50%, 52.94%, and 100%) with 17 patients (43.59%) had mortality. Conclusion: While Boey and POMPP score are most commonly used to predict outcome for PPU patients in Dr. Soetomo General Hospital, considerable variations in risk of mortality were shown. Therefore, both Boey and POMPP score had its own advantages and disadvantages. Further prospective research is needed to test the validity of Boey and POMPP scoring systems, thus the scoring systems can be used in daily hospital practice in patients with PPU.

EARLY DETECTION OF BREAST AND CERVICAL CANCER OF THE RESIDENTS OF PROPPO PAMEKASAN DISTRICT Dyah Fauziah; Alphania Rahniayu; Nila Kurniasari; Anny Setijo Rahaju; Etty Hary Kusumastuti; Gondo Mastutik; I Ketut Sudiana
Jurnal Pengabdian Masyarakat Dalam Kesehatan Vol. 3 No. 1 (2021): APRIL 2021
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/jpmk.v3i1.21584

Introduction: Breast cancer and cervical cancer are common cancers in females. Both of these cancers can be detected early. Early detect vion can reduce cancer morbidity and mortality. The community outreach activities are required to increase knowledge about breast cancer and cervical cancer, in addition to screening as preventive efforts for these two cancers.Methods: The activity of raising knowledge about the prevention and early detection of breast cancer and cervical cancer was carried out through community counseling to 94 females who were members of the PKK and young females in the Kecamatan Proppo, Kabupaten Pamekasan. Pre and post tests were given before and after the community counseling. After the community counseling, 86 participants were screened for breast cancer by clinical palpation and 46 participants were screened for cervical cancer using the pap smear method.Results: The result of the post test showed a 27.53% increase in knowledge. The results of the pap smear examination on participants showed 96% concluded as Papanicolau Class II, 2% Class I, and 2% Class IV. The patient with class IV results was referred to an obstetrician.Conclusion: Community counseling about breast self examination (BSE) and Pap smear can increase people's knowledge about early detection of breast cancer and cervical cancer.

Hubungan Peritoneal Carcinomatosis Index dan Predictive Index Value Fagotti dengan Kadar Serum Fatty Acid Binding Protein 4 pada Kanker Ovarium Epitel Stadium Lanjut MUHAMMAD RIZKI YAZNIL; BRAHMANA ASKANDAR TJOKROPRAWIRO; DYAH FAUZIAH
Indonesian Journal of Cancer Vol 11, No 3 (2017): July - September 2017
Publisher : National Cancer Center - Dharmais Cancer Hospital

In advanced ovarian cancer, the main goal of surgery is complete debulking with no visible residual tumor, and predicting it before surgery has become a goal that still unresolved. The ability in advanced ovarian cancer surgery varied between healthcare facilities. Recent discovery put forward the role of fatty acid as one of the main source of energy for ovarian cancer aggresiveness and the role of fatty acid binding protein (FABP) escpecially FABP4 expression as an important biomarker for predicting residual disease in ovarian cancer. There are no data about FABP4 serum in ovarian cancer and it’s role in predicting the extensiveness of advanced stage ovarian cancer. To evaluate correlation between FABP4 serum level with PIV Fagotti Score and Peritoneal Carcinomatosis Index (PCI) in advanced stage ovarian cancer. Analytic observational study. Among 28 subjects, most age groups (46.4%) are 40–45 years of age, 46.4% with normal body mass index, 71.4% with ovarian cancer stage IIIC, 75% with high grade serous adenocarcinoma, average ascites volume 3232.1 ± 2006.9 mL, median CA125 serum 1094 u/mL (12–19425 u/mL). The rate of optimal and complete debulking is 53.5% from 28 subjects. Strong expression of FABP4 on 42.9% subjects. MeanFABP serum 69.6 ± 51.4 ng/mL. Mean PCI score is 14.5 (3–29), mean PIV score is 6 (2–12). There is a significant correlation between FABP4 expression and FABP4 serum level (p<0.05) with moderate power (r=0.55), and a significant correlation with moderate power (r=0.421) between FABP4 serum level with PCI and PIV score. There is a significant correlation with moderate power between rising FABP4 serum and the extent of peritoneal carcinomatosis evaluated by PCI and PIV Fagotti Score in advanced stage ovarian cancer.ABSTRAKPrediksi resektabilitas pada kanker ovarium epitel masih merupakan masalah penting yang belum terpecahkan. Penelitian-penelitian mutakhir mengemukakan peran dari asam lemak sebagai salah satu sumber energi penting bagi progresivitas kanker ovarium. FABP4 sebagai salah satu protein yang berperan dalam transportasi asam lemak merupakan salah satu biomarker yang dijumpai pada kanker ovarium dengan residu tumor. Akan tetapi, penelitian mengenai kadar serum FABP4 pada stadium lanjut belum ada. Selain itu, apakah PCI dan PIV skor Fagotti mempunyai hubungan dengan kadar serum FABP4 pada kanker ovarium stadium lanjut belum pernah diteliti. Penelitian ini bertujuan untuk menilai korelasi antara PIV skor Fagotti dan PCI dengan kadar serum FABP4 pada penderita kanker ovarium stadium lanjut. Observasional analitik digunakan dalam penelitian ini, di mana peneliti ingin melihat korelasi antara nilai skor PIV skor Fagotti dan PCI dengan kadar serum FABP4. Subjek penelitian berjumlah 28 orang dengan karakteristik: kelompok usia terbanyak 40–45 tahun (46,4%); indeks massa tubuh normal (46,4%); stadium FIGO IIIC (71,4%); high grade serous ovarian cancer (75%); jumlah rerata asites 3232,1 ± 2006,9 mL; median kadar serum CA125 1094 u/mL (12–19425 u/mL); 53,5% subjek dapat dilakukan sitoreduksi optimal dan komplit. Ekspresi FABP4 yang kuat terjadi pada 42,9% subjek. Rerata kadar serum FABP4 69,6 ± 51,4 ng/mL. Korelasi signifikan antara ekspresi FABP4 dengan kadar serum FABP4 pada penelitian ini (p<0,05), dengan tingkat korelasi sedang (r=0,55). Rerata PCI total 14,5. Rerata PIV adalah 6 dengan nilai minimum 2 dan maksimum 12.Didapatkan korelasi signifikan (p<0,05) antara kadar serum FABP4 dengan penilaian PCI dan PIV dengan tingkat korelasi sedang (r=0,421, r=0,458). Pada penelitian ini ditemukan korelasi signifikan dengan kekuatan korelasi sedang antara peningkatan skor PIC dan PIV skor Fagotti dengan peningkatan kadar serum FABP4 pada pasien kanker ovarium stadium lanjut.

Hubungan Invasi Pembuluh Limfe Dengan Metastasis ke Kelenjar Getah Bening Pelvis pada Kanker Serviks Stadium IB dan IIA MANUEL HUTAPEA; SUHATNO -; DYAH FAUZIAH
Indonesian Journal of Cancer Vol 8, No 1 (2014): Jan - Mar 2014
Publisher : National Cancer Center - Dharmais Cancer Hospital

Objective: to know the result of Hematoxyllin-eosin and immunostainning D2-40 Podoplanin examination in detecting lymph vessel invasion (LVI) and to analyze correlation between lymph vessel invasion with pelvic lymph node metastasis in stage IB and IIA cervical cancer. Design of this research was cross-sectional study. The clinicopathological data of 41 patients with stage IB and IIA cervical cancer who underwent radical hysterectomy and pelvic lymphadenectomy (RHPL) at Dr. Soetomo Hospital, Surabaya, from January 2008 to June 2013 were retrospectively reviewed. Age, histology type, clinical stage, tumor size, number of removed pelvic lymph node, parametrial invasion and LVI were analyzed to define their correlation with pelvic node metastases. Immunohistochemical staining using MAb-D2-40 Podoplanin was used to detect lymph vessel invasion on the corresponding HE slides. Eligible criteria are paraffin wax embedded tissue from cervix cancer patients was diagnosed as cervix cancer, and patients medical record can be found and filled completely. Ineligible criteria are patients which is had chemotherapy or radiotherapy before surgery or patients paraffin wax embedded tissue was damaged. The correlation among variables was analyzed using Phi correlation test. Results: among of total 41 patients , lymph vessel invasion (LVI) was detected in 7 (17.07%) D2-40 Podoplanin slides, and 9 (21.95%) HE slides. Agreement rate with Kappa statistic between two method was significant, k = 0,381, p = 0,014. Lymph node metastasis was found in 6 (14.63%) samples. Positive LVI detected by D2-40 Podoplanin was significantly correlated with lymph node metastasis (? = 0.362; p = 0.02), but positive LVI detected by HE was not significantly correlated (? = 0.281; p = 0.072).

Correlation of CD133 and SOX2 Expression with Regional Lymph Nodes Metastatic Status in Invasive Breast Carcinoma of No Special Type Dyah Fauziah; Sutrisno Sutrisno; Gondo Mastutik
Indonesian Journal of Cancer Vol 15, No 1 (2021): March
Publisher : National Cancer Center - Dharmais Cancer Hospital

Background: CD133 overexpression can increase cell proliferation, migration, and epithelialmesenchymal transition that promotes metastasis. CD133 expression is induced by hypoxiainduced factor (HIF) which requires SOX2 binding in the promoter region. SOX2 is an embryonal transcription factor that plays a role in the development of malignancy. The study aimed to analyze the expression of CD133 and SOX2 with regional lymph nodes (LN) metastatic status in invasive breast carcinoma of no special type (NST). Methods: The study was a cross-sectional design. Forty-five samples were retrieved from pathology archives in Dr. Soetomo Hospital from January to December 2018. Samples were divided into 2 groups, with and without regional LN metastasis. Immunohistochemistry with CD133 and SOX2 was applied to all samples. CD133 expression was assessed by immunoreactive score, and SOX2 expression was assessed by the percentage of tumor positive cells.Results: There was no significant difference in CD 133 expression between invasive breast carcinoma of NST with and without regional LN metastases (P = .990). A positive correlation was found in SOX2 expression between breast carcinoma with and without regional LN metastasis (P = .000; rs = .518). There was no correlation between CD133 and SOX2 expression (P = .082), which means that the high expression of CD133 did not affect SOX2 expression.Conclusions: CD133 expression was not significantly different in breast carcinoma with and without LN metastasis. The high expression of SOX2 was found significantly correlated with regional LN metastasis. SOX2 expression may become a potential prognostic marker in invasive breast carcinoma of NST. regional LN metastasis

Ekspresi p53 Mutan dan caspase 3 sebagai Faktor Prediksi terhadap Operabilitas Kanker Serviks IIB setelah Mendapat Kemoterapi Neoajuvan Teguh Prakosa; Brahmana Askandar; Dyah Fauziah
Indonesian Journal of Cancer Vol 7, No 2 (2013): Apr - Jun 2013
Publisher : National Cancer Center - Dharmais Cancer Hospital

Tujuan: untuk mengetahui ekspresicaspase3 dan p53 mutan dalam memprediksi respons operabilitas (pra-operatif) pada penderita kanker serviks IIB yang mendapatkan kemoterapi neoajuvanpaclitaxel-platinum.Metode: ekspresicaspase3 dan p53 mutan diperiksa dengan pengecatan immunohistokimia pada 40 potongan biopsi jaringan pasien kanker serviks IIB yang memenuhi kriteria inklusi, yang melakukan pengobatan di RSUD dr. Soetomo, Departemen Obstetri dan Ginekologi, Fakultas Kedokteran Universitas Airlangga, Surabaya mulai bulan Desember 2006 hingga Juli 2011. Kriteria inklusi meliputi penderita kanker serviks IIB yang mendapatkan rejimen kemoterapi neoajuvanpaclitaxel-platinum(cisplatin 75 mg/m2 atau carboplatin AUC 5 paclitaxel175 mg/m2) sebanyak tiga seri berturut-turut 3 mingguan dan telah dilakukan evaluasi operabilitasnya pasca-kemoterapi neoajuvan yang dilakukan sebelum operasi, 3 minggu sampai 4 minggu setelah kemoterapi yang terakhir. Penelitian ini merupakan studi analitik dengan studi kasus kontrol.Hasil: hubungan antara ekspresi p53 mutan dancaspase3 dengan operabilitas post kemoterapi neoajuvanpaclitaxel-platinumdianalisis dengan uji regresi logistik sederhana. Dari penelitian ini didapatkan sejumlah 22 (55%) pasien kanker serviks IIB yang mendapat kemoterapi neoajuvan memberikan responsinoperabledan 18 (45%) pasien memberikan respons operabel. Ekspresi p53 mutan terbanyak menunjukkan hasil ekspresi negatif, dengan rentang skor 0-1, yaitu sebanyak 33 (82,5%) penderita. Ekspresi positif didapatkan pada 7 (17,5 %) penderita, dan tidak didapatkan perbedaan yang signifikan (p 0,48; OR: 0,55 (CI 95%:0,11-2,87)). Jumlah ekspresicaspase3 yang positif dan negatif menunjukkan jumlah yang sama besarnya baik pada luaran inoperabel maupun operabel, yaitu masing-masing 13 (72,2%) dan 11 (50,0%); dengan p=0,158, OR:2,60(CI 95%:0,69-9,81).Kesimpulan: ekspresicaspase3 dan p53 mutan tidak dapat memprediksi respons operabilitas pada pasien kanker serviks IIB yang mendapatkan kemoterapi neoajuvanpaclitaxel-platinum.Kata kunci: kanker serviks stadium IIB, kemoterapi neoajuvanpaclitaxel-platinum, operabilitas pascakemoterapi neoajuvan

Ekspresi Heat Shock Protein 70 (HSP70) dan Caspase-3 sebagai Prediktor terhadap Operabilitas Kanker Serviks Stadium IIB setelah Mendapat Kemoterapi Neoajuvant Paclitaxel-Carboplatin Hermawan Udiyanto; Brahmana Askandar; Dyah Fauziah
Indonesian Journal of Cancer Vol 7, No 3 (2013): Jul - Sep 2013
Publisher : National Cancer Center - Dharmais Cancer Hospital

Penelitian ini bertujuan untuk mengetahui peran ekspresi HSP70 dan Caspase-3 terhadap keberhasilan operabilitas kanker serviks stadium IIB setelah pemberian kemoterapi neoajuvant Paclitaxel-Carboplatin 3 seri. Metode: ekspresi HSP70 dan caspase-3 diperiksa dengan pengecatan imunohistokimia pada 40 potongan biopsi jaringan pasien kanker serviks IIB yang memenuhi kriteria inklusi, yang melakukan pengobatan di RSUD dr. Soetomo, Departemen Obstetri dan Ginekologi, Fakultas Kedokteran Universitas Airlangga, Surabaya, mulai Desember 2006 hingga Juli 2011. Kriteria inklusi meliputi penderita yang telah dilakukan evaluasi keberhasilan terapi (operabilitas) pasca-kemoterapi neoajuvant Paclitaxel-Carboplatin sebanyak 3 seri berturut-turut, dengan interval pemberian 3 minggu. Evaluasi keberhasilan terapi (operabilitas) tidak mengikuti kriteria respons terapi berdasarkan RECIST (Response Evaluation Criteria in Solid Tumours). Waktu pemeriksaan 3 4 minggu setelah pemberian kemoterapi yang terakhir. Operabilitas tumor, yaitu kondisi klinis kanker serviks di mana pada pemeriksaan dalam vagina (vaginal toucher/VT) dan pemeriksaan dalam rektum oleh tim ginekologi onkologi setelah penderita mendapatkan kemoterapi neoajuvant Paclitaxel-Carboplatin 3 seri dinyatakan bahwa pada parametrium secara klinis tidak didapatkan infiltrasi tumor. Jenis dan bentuk penelitian ini merupakan penelitian analitik observasional, studi case control pada penderita kanker serviks IIB yang mendapat kemoterapi neoajuvant Paclitaxel-Carboplatin sebanyak 3 kali dengan interval pemberian kemoterapi 3 minggu.Hubungan antara ekspresi HSP70 dan caspase-3 dengan operabilitas post-kemoterapi neoajuvant Paclitaxel-Carboplatin dianalisis dengan regresi logistik. Ekspresi HSP70 negatif dan HSP70 positif mempunyai jumlah total yang sama, yaitu 20 orang (50%), masing-masing 9 orang pada kelompok operabel dan 11 orang pada kelompok inoperabel. Tidak ada perbedaan yang bermakna hubungan antara HSP70 dengan operabilitas ( p = 1 ), dengan OR = 1,00 ( 95%CI : 0,28-3,47 ). Ekspresi caspase-3 positif sebanyak 24 orang (60,0%), masing-masing 13 orang pada kelompok operabel dan 11 orang pada kelompok inoperabel. Pada ekspresi Caspase-3 negatif, sebanyak 16 orang (40,0%), masing-masing 5 orang pada kelompok operabel dan 11 orang pada kelompok inoperabel. Tidak ada perbedaan yang bermakna hubungan antara ekspresi caspase-3 dengan operabilitas ( p = 0,154 ), dengan OR = 0,06 ( 95%CI : 0,69-9,81). Kombinasi antara ekspresi HSP70 (+) dan ekspresi caspase-3 (-), sebanyak 8 orang (20%), masing-masing 2 orang pada kelompok operabel dan 6 orang pada kelompok inoperabel. Sedangkan pada kelompok selain kombinasi antara ekspresi HSP70 (+) dan ekspresi caspase-3 (-) sebanyak 32 orang (80%), masing-masing 16 orang pada kelompok inoperabel dan 16 orang pada kelompok operabel. Tidak ada perbedaan yang bermakna hubungan antara kombinasi ekspresi HSP70 (+) dan ekspresi caspase-3 (-) dengan operabilitas ( p = 0,217 ), dengan OR = 3,0 ( 95 % CI : 0,525-17,159).Kesimpulan: ekspresi HSP70 dan caspase-3 tidak dapat dijadikan sebagai prediktor operabilitas pada kanker serviks stadium IIB yang mendapatkan neoajuvant kemoterapi Paclitaxel-Carboplatin.Kata kunci: Kanker serviks stadium IIB, kemoterapi neoajuvant Paclitaxel-Carboplatin, operabilitas pascakemoterapi neoajuvant.

Ekspresi Heat Shock Protein 70 (HSP-70) dan P53 Mutan sebagai Faktor Prediksi Operabilitas Pasca-kemoterapi Neoajuvan pada Kanker Serviks IIB ROY YUSTIN SIMANJUNTAK; BRAHMANA ASKANDAR; DYAH FAUZIAH
Indonesian Journal of Cancer Vol 6, No 4 (2012): Oct - Dec 2012
Publisher : National Cancer Center - Dharmais Cancer Hospital

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33371/ijoc.v6i4.293

Tujuan: untuk mengetahui ekspresi HSP-70 dan p53 mutan dalam memprediksi respons operabilitas (pra-operatif) pada penderita kanker serviks IIB yang mendapatkan kemoterapi neoajuvan Paclitaxel-Platinum. Metode: penelitian ini merupakan studi analitik dengan pendekatan kasus kontrol. Ekspresi p53 mutan dan HSP 70 diperiksa dengan pengecatan imunohistokimia pada 40 potongan biopsi jaringan pasien kanker serviks IIB yang memenuhi kriteria inkluasi, yang melakukan pengobatan di RSUD dr. Soetomo, Departemen Obstetri dan Ginekologi, Fakultas Kedokteran Universitas Airlangga, Surabaya, mulai Desember 2006 hingga Juli 2011. Kriteria inklusi meliputi ukuran tumor ? 4 cm, telah dievaluasi operabilitas melalui pemeriksaan klinis dan mendapatkan kemoterapi neoajuvan Paclitaxel-Platinum (setiap 3 minggu selama 3 siklus).Hasil: dari penelitian ini didapatkan total sampel sebanyak 40 pasien yang mendapat kemoterapi neoajuvan Paclitaxel- Platinum. Dari 40 sampel tersebut, 22 (55%) pasien kanker serviks IIB memberikan respons inoperable dan 18 (45%) pasien memberikan respons operabel. Ekspresi p53 mutan terbanyak menunjukkan hasil ekspresi negatif, dengan rentang skor 0-1, yaitu sebanyak 33 (82,5%) penderita. Ekspresi positif didapatkan pada 7 (17,5%) penderita dan tidak didapatkan perbedaan yang signifikan (p 0,48; OR: 0,55 (CI 95%:0,11- 2,87)). Jumlah ekspresi HSP 70 yang positif dan negatif menunjukkan jumlah yang sama besarnya, baik pada luaran inoperabel maupun operabel, masing-masing 11 (50,0%) dan 9 (50,0%), dengan p=1,00, OR: 1,00 (CI 95%:0,289-3,48). Hubungan antara ekspresi p53 dan HSP 70 dengan operabilitas post kemoterapi neoajuvan Paclitaxel-Platinum dianalisa dengan uji Chi-square.Kesimpulannya, ekspresi HSP 70 dan p53 mutan tidak dapat memprediksi respons operabilitas pada pasien kanker serviks IIB yang mendapatkan kemoterapi neoajuvan Paclitaxel-Platinum.Kata kunci: Kanker serviks stadium IIB, kemoterapi neoajuvan Paclitaxel- Platinum, operabilitas pasca-kemoterapi neoajuvan.

AGE AND BODY MASS INDEX IN TYPE I ENDOMETRIAL CANCER GRADE Gilang Adi Firmansyah; Dyah Fauziah; Brahmana Askandar Tjokroprawiro
Majalah Biomorfologi Vol. 32 No. 2 (2022): MAJALAH BIOMORFOLOGI
Publisher : Universitas Airlangga, Surabaya, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/mbiom.v32i2.2022.73-81

Highlights: 1. The major risk factors for type I endometrial cancer, namely age and obesity, play a major role in the increase in this case and are thought to be related to the grade in these cancer patients.2. Type I endometrial cancer patients at Dr. Soetomo General Academic Hospital 2019-2020 are dominated by patients diagnosed at the age of 56-65 years, having an overweight body mass index (23-24.9 kg/m2).3. The patient's age and body mass index did not correlate with endometrial cancer type I grade. Abstract Background: The increase in obesity and life expectancy has contributed to type I endometrial cancer cases worldwide. Increased risk factors play a role in the increase of these cases. Objectives: To determine the relationship between age and BMI with the cancer grade. Material and Method: This research was a cross-sectional study. The data were obtained from the patient’s medical records. The sampling technique was total sampling. The analysis used was Spearman Rho correlation test for the relationship between age and BMI with cancer grade. Results: This study recorded 54 patients with type I endometrial cancer in Dr. Soetomo General Academic Hospital, Surabaya, Indonesia, from 2019 to 2020. The patients were from the age group 56-65 years 25 patients (46.30%), 46-55 years 17 patients (31.48%), 36-45 years 8 patients (14.81%), 26-35 years 2 patients (3.7%), and >65 years 2 patients (3.7%). For BMI, the patients were overweight (23-24.9 kg/m2) 21 patients (38.89%), normal (18.5-22.9 kg/m2) 14 patients (25.93%), obesity (25-29.9 kg/m2) 12 patients (22.22%), and obesity II (≥30 kg/m2) 7 patients (12.96%). For grade, grade III were 22 patients (40.75%), grade II 20 patients (37.04%), and grade I 12 patients (22.22%). There was a weak, insignificant positive correlation between age with grade (ρ=0.116, 0.405>α=0.05) and a weak, insignificant negative correlation between BMI with grade (ρ=-0.206, 0.135>α=0.05). Conclusion: A total of 54 patients with type I endometrial cancer at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia, from 2019-2020 aged 56-65 years and overweight (23-24.9 kg/m2) with grade III cancer. The patient's age and BMI did not correlate with the patient's grade.

PENYULUHAN TENTANG TANDA AWAL DAN DETEKSI DINI TUMOR GANAS PAYUDARA PADA WARGA DI PUSKESMAS SEMEMI KECAMATAN BENOWO KOTA SURABAYA Nila Kurniasari; Gondo Mastutik; Dyah Fauziah; Etty Hary Kusumastuti; Alphania Rahniayu; Anny Setijo Rahaju
Jurnal Layanan Masyarakat Vol. 6 No. 2 (2022): JURNAL LAYANAN MASYARAKAT
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/jlm.v6i2.2022.251-258

Kanker payudara merupakan keganasan paling sering dan penyebab kematian tertinggi. Di Indonesia, kanker payudara juga merupakan kanker paling sering dan penyebab kematian kedua setelah kanker paru. Hal ini tejadi karena kanker payudara sering terdiagnosis pada stadium lanjut sehingga menyebabkan kegagalan pengobatan dan kematian. Kejadian kanker payudara stadium lanjut ini dapat dicegah dengan deteksi dini, namun masyarakat masih mempunyai pengetahuan yang rendah tentang tanda awal kanker payudara. Tujuan dari kegiatan ini adalah untuk memberikan penyuluhan tentang tanda awal dan deteksi dini tumor ganas di payudara. Kegiatan dilaksanakan pada 11 November 2020, diikuti oleh 91 orang ibu PKK di wilayah kerja Pusat Kesehatan Masyarakat (Puskesmas) Sememi, Kecamatan Benowo Kota Surabaya. Kegiatan diawali pre-test dan pengisian kuisioner faktor risiko, kemudian dilanjutkan dengan pemberian penyuluhan melalui aplikasi zoom meeting dan diakhiri dengan post-test. Evaluasi dilakukan dengan membandingkan hasil pre-test dan post-test. Hasil kuisioner menunjukkan terdapat peningkatan pemahaman tentang tanda awal dan deteksi dini kanker payudara sebesar 6,96%. Faktor risiko peserta menderita kanker payudara menunjukkan bahwa sebagian besar peserta penyuluhan tidak berisiko menderita kanker payudara karena tidak merokok (100%), tidak mempunyai riwayat benjolan pada payudara (97,14%), menyusui lebih dari 6 bulan (88,57%), tidak terpapar radiasi sinar X (88,57%), mempunyai anak (85,71%), tidak mempunyai riwayat keluarga yang pernah menderita tumor atau kanker (71,43%), rutin berolah raga (60%), namun terdapat 97,14% yang berusia lebih dari 25 tahun sehingga masih mempunyai faktor risiko menderita kanker payudara. Kesimpulan. Terdapat peningkatan pengetahuan masyarakat sebesar 6.96% dan sebagain besar peserta penyuluhan tidak memiliki faktor risiko untuk terjadi kanker payudara.

Co-Authors Agung Dwi Suprayitno Agustin, Leonita Alpha Fardah Athiyyah Alphania Rahniayu Anak Agung Gede Sugianthara Anang Endaryanto Andi Syarti Anggoro, Adhitri Anny Setijo Rahaju, Anny Setijo Ariani, Grace Arif Satria Hardika Askandar Tjokroprawiro Barliana Barliana Budi Utomo Cindy Angelina Limantara Cita Rosita Sigit Prakoeswa Deasy Fetarayani Dewi Astuti Kurniawati Dewi Sartika A. W. Dian Yuliartha Lestari Diana Purnamasari Djuanda, Stephanie N. Dwirani Rosmala Pratiwi Dyah Erawati Edi Suyanto Elvin Nuzulistina Emillia Wijayanti Esti Hindariati Faradila Budi Saputri Faroek Hoesin Febrina Diah Puspitasari Ferdiansyah Mahyudin Fira Soraya Fitriana . Gatot Soegiarto Gilang Adi Firmansyah Gondo Mastutik Gunawan, Vania A. Heriyawati, Heriyawati Hermawan Udiyanto Ilmiah, Khafidhotul Imam Susilo INDRA YULIATI, INDRA Ingrid Suryanti Surono Khafidhotul Ilmiah Kusumastuti , Etty Hary Kusumastuti, Etty H. Kusumastuti, Etty Hari KUSUMASTUTI, ETTY HARY Lefi, Achmad Lies Mardiyana, Lies Lilihata, Jilientasia G. Maharani, Andi RK. Mamiek Dwi Putro MANUEL HUTAPEA MANUEL HUTAPEA, MANUEL Marhana, Isnin A. Mega Kahdina Meyta Riniastuti MUHAMMAD RIZKI YAZNIL Nabilah Puspa Utami Nasrun Bakri Nila Kurniasari Nila Kurniasari Nugraha, Ricardo A. Nugroho, Gilang MS. Nunuk Mardiana, Nunuk Prastiya Indra Gunawan Qonitatillah, Ana Rahaju, Anny S. Rahmadewi Rahmadewi Retnani, Diah Prabawati Ridholia Ridholia Ridholia Ridholia, Ridholia Rinjani, Lalu GP. Rizkie T Trisnawaty Rosyid, Alfian N. ROY YUSTIN SIMANJUNTAK ROY YUSTIN SIMANJUNTAK, ROY YUSTIN S.Pd. M Kes I Ketut Sudiana . Sarah Fauzia Sari, Aditya Sita Semedi, Bambang P. SUHATNO - SUHATNO -, SUHATNO Supriadi Supriadi Sutrisno Sutrisno Teguh Prakosa, Teguh Tri Wulanhandarini Ulinta Pasaribu Ummi Maimunah wahjoe djatisoesanto Wahyu, Dwi wihasto suryaningtyas Willy Sandhika Wiratama, Priangga A. Wiratama, Priangga Adi Wirawan, Putu Tanisya Putri Yandi, I KR. Yaznil, Muhammad Rizki Yetti Hernaningsih Yuliana Kurniawati Yusuf, Muhtarum

Title

Found 51 Documents
Search

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Title Search

Found 51 Documents Search

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Title

Found 51 Documents
Search